Education
About Us
Working with TipRanks
Follow Us
Spago Nanomedical AB (DE:7UX)
FRANKFURT:7UX
7UX Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.01 - €0.03
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€6.81M
Enterprise Value€35.78M
Total Cash (Recent Filing)kr32.47M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.31
Next Earnings
May 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding348,196,200
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)48.71
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
7UX FAQ
What was Spago Nanomedical AB’s price range in the past 12 months?
Spago Nanomedical AB lowest stock price was €0.01 and its highest was €0.03 in the past 12 months.
What is Spago Nanomedical AB’s market cap?
Spago Nanomedical AB’s market cap is €6.81M.
When is Spago Nanomedical AB’s upcoming earnings report date?
Spago Nanomedical AB’s upcoming earnings report date is May 07, 2025 which is in 10 days.
How were Spago Nanomedical AB’s earnings last quarter?
Spago Nanomedical AB released its earnings results on Feb 06, 2025. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.002.
Is Spago Nanomedical AB overvalued?
According to Wall Street analysts Spago Nanomedical AB’s price is currently Overvalued.
Does Spago Nanomedical AB pay dividends?
Spago Nanomedical AB does not currently pay dividends.
What is Spago Nanomedical AB’s EPS estimate?
Spago Nanomedical AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Spago Nanomedical AB have?
Spago Nanomedical AB has 348,196,200 shares outstanding.
What happened to Spago Nanomedical AB’s price movement after its last earnings report?
Spago Nanomedical AB reported an EPS of -€0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Spago Nanomedical AB?
Currently, no hedge funds are holding shares in DE:7UX
---
Company Description
Spago Nanomedical AB
Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging (MRI) through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer.
---
Technical Analysis
OncoZenge AB
―
Modus Therapeutics Holding AB
―
ExpreS2ion Biotech Holding AB
―
CombiGene AB
―
Bio-Works Technologies AB
―
---